Atea Pharmaceuticals, Inc. (AVIR) ownership: Top institutional holder: FMR LLC ($64.30M). Insider activity: Net Seller (5 buys, 15 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 11950772.00 | $64.30M | 2026-03-31 |
| BlackRock, Inc. | 8435437.00 | $45.38M | 2026-03-31 |
| BML Capital Management, LLC | 7058657.00 | $37.98M | 2026-03-31 |
| TANG CAPITAL MANAGEMENT LLC | 4814700.00 | $25.90M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3246124.00 | $17.46M | 2026-03-31 |
| VANGUARD GROUP INC | 4227110.00 | $15.09M | 2025-12-31 |
| Bain Capital Life Sciences Investors, LLC | 2360638.00 | $12.70M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 1864164.00 | $10.03M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-18 | |
| Buy | null | 2026-05-18 | |
| Buy | null | 2026-05-18 | |
| Sell | null | 2026-03-11 | |
| Sell | null | 2026-03-11 | |
| Sell | null | 2026-03-11 | |
| Sell | null | 2026-03-11 | |
| Sell | null | 2026-02-03 |
Back to AVIR overview · AVIR earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.